Both in Pharmaceuticals
Amneal Pharmaceuticals vs Ligand Pharmaceuticals
Over the past year AMRX returned +80.5% and LGND returned +63.9%; their daily moves had a correlation of 0.29.
AMRX +80.5% LGND +63.9%Growth of $1, one year, split-adjusted
| Metric | AMRX | LGND |
|---|---|---|
| Price | $20.21 | $313.52 |
| Market cap | $7.04B | $6.27B |
| Today | −1.13% | +2.12% |
| 1 month | −0.7% | +2.2% |
| 6 months | +50.7% | +35.0% |
| Year to date | +60.4% | +65.8% |
| 1 year | +86.8% | +63.9% |
| Revenue growth (YoY) | +9.9% | −31.8% |
| Gross margin | 42.0% | 83.7% |
| Net margin | 7.2% | −36.2% |
| P/E (TTM) | 44.7× | 121.9× |
| Price / sales | 2.3× | 24.7× |
| Net cash | -$2.54B | -$653.3M |
| Dividend yield | — | — |
| Volatility (60d) | 39.1% | 29.7% |
| Short % of float | 8.2% | 13.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).